Multinational companies that invest heavily in research and development and
other forms of intangible assets be warned. This year the taxman is likely to be
paying more attention to how these forms of intellectual property are
transferred within companies.
Transfer pricing, which refers to the price that units of the same company
charge each other for goods and services, accounts for more than half of all
world trade. Companies are supposed to charge market rates for the internal
transactions, setting prices at so-called ‘arms length’.
But tax authorities believe large companies use transfer pricing to charge
artificial prices for internal transfers to avoid tax by moving their profits to
HM Revenue & Customs is expected to introduce a framework for penalties
applied to erroneous transfer pricing documentation in April this year. It is
thought the minimum penalty applied will be 10% of the total tax lost to HMRC,
with the total penalty depending on the severity of the error.
So far, the UK taxman has focused on what constitutes the market value of
tangible goods and services when exchanged within a multinational company and
whether the rate applied reflects the market.
However, tax experts believe that HMRC is likely to start paying more
attention to the transfer pricing of intellectual property.
The pricing of IP is particularly relevant in sectors such as
pharmaceuticals, where companies spend billions of pounds on research and
development. In 2006
GlaxoSmithKline, the world’s second biggest drugs manufacturer, was fined
$3.4bn (£2.3bn) by the US Internal Revenue Service (IRS).
But placing a value on intangibles such as commercial ideas, know-how,
brands, patents and processes is difficult, according to Bill Dodwell, head of
tax policy at Deloitte.
He added that tax authorities and companies would struggle to reach agreement
on IP values.
Andrew Hickman, a transfer pricing partner at KPMG, said companies that
transfer more intangible assets than goods and services within their group run a
greater risk of tax investigations, due to uncertainty over the value of IP.?
Introduced in 2013 to encourage R&D investment, the scheme allows UK businesses to pay only 10% corporation tax on profits derived from any UK or certain EU patents
Yet, KPMG’s annual survey shows that the UK is still an attractive place to do business, despite falling in rankings in tax competitiveness and FDI appeal
MTD cost estimates are not based on 'facts', and are 'disbelieved' by most small businesses and sole traders, says Lords committee chairman
MTD represents 'the single most significant change to the UK’s system of taxation in recent times', says Knill James partner Nick Rawson. So, how prepared are SMEs for digital tax reporting?